No Data
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
Qualigen Therapeutics | 10-Q: Q3 2024 Earnings Report
Qualigen Therapeutics Names Graydon Bensler to Board
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Qualigen Therapeutics To Carry Out 1-for-50 Reverse Stock Split On November 5th, 2024
November 1st (Eastern Time) - $Qualigen Therapeutics(QLGN.US)$ is about to implement a 1-for-50 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from November 5
Qualigen Therapeutics 1-For-50 Reverse Stock Split, Expected To Begin Trading On Split-Adjusted Basis On November 5, 2024
No Data
No Data